New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia

Cristina Alonso-Vega, Julio A Urbina, Sergi Sanz, María-Jesús Pinazo, Jimy José Pinto, Virginia R Gonzalez, Gimena Rojas, Lourdes Ortiz, Wilson Garcia, Daniel Lozano, Dolors Soy, Rosa A Maldonado, Rana Nagarkatti, Alain Debrabant, Alejandro Schijman, M Carmen Thomas, Manuel Carlos López, Katja Michael, Isabela Ribeiro, Joaquim Gascon, Faustino Torrico, Igor C Almeida

Open source

DOI: 10.1136/bmjopen-2021-052897
Published: 2021-12
Container: BMJ Open
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2021-052897,
  title = {New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia},
  author = {Cristina Alonso-Vega and Julio A Urbina and Sergi Sanz and María-Jesús Pinazo and Jimy José Pinto and Virginia R Gonzalez and Gimena Rojas and Lourdes Ortiz and Wilson Garcia and Daniel Lozano and Dolors Soy and Rosa A Maldonado and Rana Nagarkatti and Alain Debrabant and Alejandro Schijman and M Carmen Thomas and Manuel Carlos López and Katja Michael and Isabela Ribeiro and Joaquim Gascon and Faustino Torrico and Igor C Almeida},
  year = {2021},
  journal = {BMJ Open},
  doi = {10.1136/bmjopen-2021-052897},
  url = {https://doi.org/10.1136/bmjopen-2021-052897}
}

RIS

TY  - JOUR
TI  - New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia
AU  - Cristina Alonso-Vega
AU  - Julio A Urbina
AU  - Sergi Sanz
AU  - María-Jesús Pinazo
AU  - Jimy José Pinto
AU  - Virginia R Gonzalez
AU  - Gimena Rojas
AU  - Lourdes Ortiz
AU  - Wilson Garcia
AU  - Daniel Lozano
AU  - Dolors Soy
AU  - Rosa A Maldonado
AU  - Rana Nagarkatti
AU  - Alain Debrabant
AU  - Alejandro Schijman
AU  - M Carmen Thomas
AU  - Manuel Carlos López
AU  - Katja Michael
AU  - Isabela Ribeiro
AU  - Joaquim Gascon
AU  - Faustino Torrico
AU  - Igor C Almeida
PY  - 2021
JO  - BMJ Open
DO  - 10.1136/bmjopen-2021-052897
UR  - https://doi.org/10.1136/bmjopen-2021-052897
ER  -

APA

Alonso-Vega, C., Urbina, J. A., Sanz, S., Pinazo, M., Pinto, J. J., Gonzalez, V. R., Rojas, G., Ortiz, L., Garcia, W., Lozano, D., Soy, D., Maldonado, R. A., Nagarkatti, R., Debrabant, A., Schijman, A., Thomas, M. C., López, M. C., Michael, K., Ribeiro, I., Gascon, J., Torrico, F., & Almeida, I. C. (2021). New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia. BMJ Open. https://doi.org/10.1136/bmjopen-2021-052897

Source records

crossref · retrieved 2026-09-27T09:56:38.952Z